Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187239 · ClinicalTrials.gov registry record · Phase 4
Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search Study
A Phase 4 study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- Phase 4
- Development phase
- 157
- Enrollment target
NCT00187239 is a Phase 4 study that has completed, run by Abbott Medical Devices. The registered enrollment target is 157 participants.
The verdict
NCT00187239, a Phase 4 study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 157 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if patients implanted with a St. Jude Medical (SJM) implantable cardioverter defibrillator (ICD) will benefit by using AutoIntrinsic Conduction Search (AICS) rather than only a programmed AV/PV delay. This study will compare the two methods of programming with respect to intrinsic activity.
Interventions
- DEVICE Autointrinsic Conduction Search Algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2005-07 |
| Est. Completion | 2007-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187239
The ClinicalTrials.gov registry entry for NCT00187239 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Autointrinsic Conduction Search Algorithm is the first listed.
NCT00187239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187239 about?
NCT00187239 is a clinical study titled "Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search Study". The purpose of this study is to determine if patients implanted with a St. Jude Medical (SJM) implantable cardioverter defibrillator (ICD) will benefit by using AutoIntrinsic Conduction Search (AICS) rather than only a programmed AV/PV delay. This study will compare the two methods of programming wi...
What is the current status of trial NCT00187239?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 157 participants. The study started on 2005-07. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00187239?
The interventions under investigation include: Autointrinsic Conduction Search Algorithm (DEVICE).
Who is sponsoring clinical trial NCT00187239?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.